Filing Flows › GoodRx Holdings (GDRX) › Pharma Direct revenue revenue
GoodRx Holdings (GDRX) Pharma Direct revenue revenue by quarter
GoodRx Holdings' Pharma Direct revenue revenue was $61.6M in Q2 2026 (second quarter 2026), +18% from Q1 2026. Over the last 6 quarters it ranged from $28.1M (Q4 2024) to $61.6M (Q2 2026).
| Quarter | Pharma Direct revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $61.6M | +18% | +76% |
| Q1 2026 | $52.2M | +20% | +82% |
| Q3 2025 | $43.4M | +24% | — |
| Q2 2025 | $35.0M | +22% | — |
| Q1 2025 | $28.6M | +2% | — |
| Q4 2024 | $28.1M | — | — |
Q2 2026 at a glance
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is GoodRx Holdings' Pharma Direct revenue revenue?
GoodRx Holdings' Pharma Direct revenue revenue was $61.6M in Q2 2026 (second quarter 2026), +18% from Q1 2026.
How has GoodRx Holdings' Pharma Direct revenue revenue changed?
Over the last 6 quarters it ranged from $28.1M (Q4 2024) to $61.6M (Q2 2026).